Entera Bio Ltd. (ENTX) Tops Q2 EPS by 5c

Entera Bio Ltd. (NASDAQ: ENTX) reported Q2 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Entera Bio Ltd. (ENTX) click here.

You May Also Be Interested In

• Citi opens 90-day upside catalyst watch on Full Truck Alliance
• Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'
• Barclays: 'IBM’s comments around client prioritization of security bodes well for the space overall'